Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium voltage-gated channel subfamily KQT member 5 (Kv7.5) is a transmembrane protein encoded by the KCNQ5 gene that forms voltage-gated potassium channels, primarily in the brain and smooth muscle [1, 2]. It is a key component of the M-current, which regulates neuronal excitability by controlling the resting membrane potential and preventing repetitive firing [1, 3]. In the central nervous system, Kv7.5 is localized in areas such as the hippocampus and cortex, where it influences synaptic plasticity and cognitive functions [3]. Pathogenic variants in KCNQ5 are linked to intellectual disability and epileptic encephalopathy, highlighting its critical role in neurodevelopment [3]. Additionally, Kv7.5 is expressed in vascular smooth muscle cells, where it contributes to the regulation of vascular tone and blood pressure [4]. Therapeutic strategies often involve positive allosteric modulators, such as retigabine, which enhance channel activity to treat conditions characterized by neuronal hyperexcitability [5]. However, developing selective ligands is difficult due to the high structural similarity between Kv7.5 and other members of the Kv7 family [5]. Sources: [1] UniProt (Q9NR82) [2] NCBI Gene (ID: 56479) [3] Lehman et al. (2017), PMID: 28942963 [4] Brueggemann et al. (2011), PMID: 21139043 [5] Gunthorpe et al. (2012), PMID: 22305715
Positive allosteric modulation (channel opening) to stabilize the resting membrane potential and reduce neuronal firing; or channel inhibition to increase excitability in specific experimental contexts [1, 5].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium voltage-gated channel subfamily KQT member 5 (KCNQ5) (Kv7.5).